new article, page-13

good call pat, with the thumbs received for gifter's post there seems to be two mindsets out there, some that have done their research and are confident with their investment and the others...

gifter in answer to your post, first research and know what you are getting into. This is a biotech not a resource stock....
Answering your points:
1. All contract work has been suspended until the main game has been achieved, this was in a previous announcement. If you look in the FQ2 report we have sales revenue from 1ml.
2. It's unfortunate we had a 2nd CR. The CFO was replaced for that earlier last year.
2a. The guy in India is eating curries & working on sales, there's regional Regulatory Approvals before sales, doesn't happen overnight(medical game).
3. Hype & market manipulation
4. ? BS
5. Not everybody fits in.... gifter?
6. contracts are contracts he did provide expertise while he was there.
7. Interesting?
8. True, all disappointed by the manipulation & lack of enthusiasm, but understandable by the hammering the SP has sustained & other sector movement.
9. very good.
10. agree, you are a Nark!
11. They would have people(experts) who have crunched the numbers.

You sound disgruntled & haven't understood what you've read in these posts, it's all been said before, so sell and move to a stock that is easier to understand.

Just last Fin.qtr an insto spend >$8M in UNIS... Why...?? They understand the stocks potential. :-)